Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events

NCT01924325 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

10000

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
TIA

Interventions

DRUG: Apixaban
DRUG: Clopidogrel
DRUG: Aspirin
DRUG: placebo

Sponsor

Xijing Hospital